The FDA emphasized that it hasn’t approved any probiotic products for infants of any age, and products haven’t been evaluated for safety, effectiveness or compliance with manufacturing and ...

Sanofi’s plan to become a dominant player in the respiratory syncytial virus (RSV) market has moved a step closer, with FDA approval of Beyfortus for the prevention of RSV disease in infants.

Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...

as well as increased goat milk based formulas being approved by the FDA, provides a new take on providing nutrition for non-breastfed or breastfed-supplemented infants.

Oct 8 (Reuters) - The U.S. health regulator has declined to approve Zealand Pharma's (ZELA.CO), opens new tab drug to prevent and treat low blood sugar in children ... US FDA approves Iterum's ...

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

Avadel Pharmaceuticals has won expanded Food and Drug Administration approval of its narcolepsy drug Lumryz for use in children. Avadel on Thursday said the FDA nod covers Lumryz for the treatment of ...

The U.S. FDA recently approved FluMist as a self or caregiver ... healthcare facilities to receive the shot. In addition, many children and adults have a fear of needles, and the nasal spray ...

Additionally, it remains the only RSV immunization approved for pregnant individuals at 32 through 36 weeks of gestation to protect infants from birth up to 6 months of age. The FDA’s decision ...

The Food and Drug Administration has granted authorization of a COVID-19 and flu test that can be used without a prescription. The authorization, announced Monday, uses a nasal swab to detect ...